ACULAR PRESERVATIVE FREE
LOE ApproachingNDAOPHTHALMICSOLUTION/DROPS
Approved
Nov 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 4h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ACULAR Preservative Free is a topical ophthalmic solution containing ketorolac tromethamine, a nonsteroidal anti-inflammatory drug (NSAID) approved for ocular use. It is administered as eye drops for short-term management of ocular itching due to seasonal allergies and post-operative inflammation. The preservative-free formulation reduces the risk of ocular surface toxicity associated with chronic exposure to benzalkonium chloride and other common preservatives.
LOE Approaching
Approaching loss of exclusivity with moderate competitive pressure (30/100), signaling potential consolidation of commercial teams and shift toward generic defense or line extension strategies.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on ACULAR Preservative Free offers limited growth trajectory and decreasing hiring volume as the product approaches loss of exclusivity. Career advancement opportunities are best suited for professionals focused on defensive commercial strategies, generic transition planning, or corporate repositioning rather than new product launches or field expansion.
Brand Manager
Worked on ACULAR PRESERVATIVE FREE at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.